Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.17
+0.06005.41%
Post-market: 1.15-0.0200-1.71%19:30 EDT
Volume:170.74K
Turnover:196.09K
Market Cap:17.71M
PE:-1.58
High:1.21
Open:1.12
Low:1.10
Close:1.11
52wk High:1.80
52wk Low:0.7500
Shares:15.14M
Float Shares:12.12M
Volume Ratio:0.27
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7393
EPS(LYR):-1.2341
ROE:-1803.19%
ROA:-134.97%
PB:6.56
PE(LYR):-0.95

Loading ...

BioCardia CEO Peter Altman buys $1,230 common shares

Reuters
·
Apr 23

BioCardia reports ‘positive’ outcome in consult with Japan’s PMDA for CardiAMP

TIPRANKS
·
Apr 20

BioCardia says Japan PMDA deems CardiAMP data sufficient for market clearance

Reuters
·
Apr 20

BioCardia gets Nasdaq notice for failing $2.5 million stockholders’ equity rule

Reuters
·
Apr 16

BioCardia Inc - Expects FDA Meeting This Quarter Under Breakthrough Designation for Cardiamp System

THOMSON REUTERS
·
Apr 02

BioCardia Inc - Submits Cardiamp HF Clinical Study Data to FDA - SEC Filing

THOMSON REUTERS
·
Apr 02

BioCardia seeks FDA meeting on accelerated approval pathway for CardiAMP in heart failure

Reuters
·
Apr 02

Press Release: Tamboran Farmout Pilot Area and BCDA Acreage for Significant Premium in Acreage Value

Dow Jones
·
Mar 30

Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and Nkarta (NKTX)

TIPRANKS
·
Mar 28

BioCardia President and CEO Peter Altman acquires common shares; purchases total $1,110

Reuters
·
Mar 27

Alliance Global Partners Sticks to Their Buy Rating for BioCardia (BCDA)

TIPRANKS
·
Mar 25

BioCardia Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 25

BioCardia Q4 EPS $(0.06) Beats $(0.17) Estimate

Benzinga Earnings
·
Mar 25

Press Release: BioCardia Reports 2025 Business Highlights and Financial Results

Dow Jones
·
Mar 25

BioCardia Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
Mar 20

BioCardia Inc. to host 2025 financial results and corporate update conference call

Reuters
·
Mar 20

BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026

GlobeNewswire
·
Mar 20

BioCardia Advances Helix Catheter Toward FDA Marketing Clearance

TIPRANKS
·
Mar 17

FDA accepts BioCardia Helix catheter pre-submission package

Reuters
·
Mar 17